Here’s what the editors at Doctor’s Briefing selected as a very powerful COVID-19 developments for you and your follow for the week of Feb. 28 to March 4, 2022. This roundup contains the most recent analysis information from journal research and different trusted sources that’s most certainly to have an effect on scientific follow.
U.S. Surgeon Basic Investigates COVID-19 Misinformation
FRIDAY, March 4, 2022 (HealthDay Information) — An investigation into well being misinformation on COVID-19 has been launched by U.S. Surgeon Basic Vivek Murthy, M.D.
NFL Drops All COVID-19 Restrictions
FRIDAY, March 4, 2022 (HealthDay Information) — The Nationwide Soccer League COVID-19 protocols will likely be lifted instantly beneath a deal reached between the league and its gamers affiliation. The settlement makes the NFL one of many first main sports activities leagues to take such motion, CBS Information reported.
Persons are additionally studying…
Molnupiravir for Nonsevere COVID-19 Added to Residing Guideline
FRIDAY, March 4, 2022 (HealthDay Information) — Molnupiravir is really useful for sufferers with nonsevere COVID-19 who’re on the highest threat for hospitalization, in response to the up to date World Well being Group residing guideline on medicine for COVID-19, printed on-line March 2 in The BMJ.
Vaccine Effectiveness Decrease for Teenagers With Predominant Omicron
THURSDAY, March 3, 2022 (HealthDay Information) — For adolescents, BNT162b2 vaccine effectiveness was decrease in opposition to COVID-19-associated emergency division and pressing care encounters throughout omicron predominance, in response to analysis printed within the March 1 early-release concern of the U.S. Facilities for Illness Management and Prevention Morbidity and Mortality Weekly Report.
Homologous Pfizer-BioNTech Booster Protected for Adolescents
THURSDAY, March 3, 2022 (HealthDay Information) — For adolescents aged 12 to 17 years, reactions to homologous Pfizer-BioNTech booster vaccination happen with comparable frequency as after receipt of the second vaccine dose, and they’re usually delicate to reasonable in severity, in response to analysis printed within the March 1 early-release concern of the U.S. Facilities for Illness Management and Prevention Morbidity and Mortality Weekly Report.
White Home Unveils New COVID-19 Response Technique
THURSDAY, March 3, 2022 (HealthDay Information) — Accelerated analysis into new vaccines that might be prepared inside 100 days of the emergence of a brand new variant is among the key options of a brand new COVID-19 response technique launched by the White Home on Wednesday.
Many Older Adults Nonetheless Have Not Acquired Care Delayed by COVID-19
THURSDAY, March 3, 2022 (HealthDay Information) — The pandemic disrupted well being look after round 30 p.c of older adults, in response to the outcomes of the most recent College of Michigan Nationwide Ballot on Wholesome Growing older.
Subsequent Vaccination Cuts Threat for COVID-19 Reinfection
THURSDAY, March 3, 2022 (HealthDay Information) — For sufferers who’ve recovered from COVID-19, the chance for recurrent an infection is decreased with receipt of not less than one dose of the BNT162b2 vaccine, in response to a examine printed on-line Feb. 16 within the New England Journal of Drugs.
CDC Estimates U.S. COVID-19 Infections Now Near 140 Million
WEDNESDAY, March 2, 2022 (HealthDay Information) — America has had about 140 million COVID-19 infections for the reason that begin of the pandemic, new information from the U.S. Facilities for Illness Management and Prevention present. That quantity is much greater than the 74.3 million confirmed COVID-19 circumstances nationwide as of Jan. 31.
Biden Unveils New ‘Check to Deal with’ Plan as Key A part of New COVID-19 Technique
WEDNESDAY, March 2, 2022 (HealthDay Information) — A brand new “check to deal with” plan will likely be a key a part of a revamped nationwide technique to return the nation to regular, President Joe Biden introduced throughout his State of the Union speech Tuesday night time.
Biden Extends FEMA COVID-19 Support to States
WEDNESDAY, March 2, 2022 (HealthDay Information) — Full protection by the U.S. Federal Emergency Administration Company for COVID-19 emergency response prices to states, tribes, and territories has been prolonged as soon as extra and can now proceed by means of July 1, the White Home stated Tuesday.
Newly Identified Diabetes at COVID-19 Admission Profiled
WEDNESDAY, March 2, 2022 (HealthDay Information) — Amongst sufferers hospitalized for COVID-19, people with newly recognized diabetes mellitus on the time of admission had decrease readings for glycemic parameters and better ranges of inflammatory markers than these with preexisting DM, in response to a examine printed on-line Feb. 4 within the Journal of Diabetes and Its Issues.
MIS-C Uncommon in 12- to 20-12 months-Olds After COVID-19 Vaccination
WEDNESDAY, March 2, 2022 (HealthDay Information) — Multisystem inflammatory syndrome in kids is uncommon after extreme acute respiratory syndrome coronavirus 2 vaccination, particularly for these with out proof of SARS-CoV-2 an infection, in response to a examine printed on-line Feb. 22 in The Lancet Youngster & Adolescent Well being.
Hyperlink Between COVID-19 Vaccination, Sudden Deafness Explored
TUESDAY, March 1, 2022 (HealthDay Information) — The potential affiliation between COVID-19 vaccination and sudden sensorineural listening to loss is unclear, in response to two research printed on-line Feb. 24 in JAMA Otolaryngology-Head & Neck Surgical procedure.
ACP Points Ultimate Follow Factors for Remdesivir Use in COVID-19
TUESDAY, March 1, 2022 (HealthDay Information) — In a residing systematic evaluation and up to date article printed on-line March 1 within the Annals of Inner Drugs, ultimate follow factors are offered to be used of remdesivir for hospitalized sufferers with COVID-19.
AAN: Tic Severity in Teenagers Tied to Social Media Use Throughout Pandemic
TUESDAY, March 1, 2022 (HealthDay Information) — Elevated use of social media in the course of the COVID-19 pandemic is correlated with elevated tic severity and decreased high quality of life amongst teenagers with tic problems, in response to a examine scheduled for presentation on the upcoming annual assembly of the American Academy of Neurology, to be held from April 2 to 7 in Seattle.
Threat for Development to Extreme COVID-19 Decrease With Nirmatrelvir + Ritonavir
TUESDAY, March 1, 2022 (HealthDay Information) — For sufferers with symptomatic COVID-19, therapy with nirmatrelvir plus ritonavir leads to a decrease threat for development to extreme COVID-19, in response to a examine printed on-line Feb. 16 within the New England Journal of Drugs.
Vaccination Ups An infection-Acquired Immunity In opposition to SARS-CoV-2
TUESDAY, March 1, 2022 (HealthDay Information) — Two doses of BNT162b2 vaccine are related to excessive short-term safety in opposition to extreme acute respiratory syndrome coronavirus 2 an infection, which wanes after six months, whereas immunity stays excessive for these with infection-acquired immunity boosted with vaccination, in response to a examine printed on-line Feb. 16 within the New England Journal of Drugs.
Almost Half of 500 Million Free COVID-19 Checks Nonetheless Left
MONDAY, Feb. 28, 2022 (HealthDay Information) — As COVID-19 circumstances throughout the US drop, almost half of the five hundred million free checks provided by the federal authorities have gone unused, in response to the White Home.
Systemic Anticancer Remedy Not Tied to Greater COVID-19 Mortality
MONDAY, Feb. 28, 2022 (HealthDay Information) — Most cancers sufferers actively receiving systemic anticancer therapy who grow to be contaminated with COVID-19 don’t expertise greater COVID-19 mortality, in response to a examine printed on-line Feb. 21 in JAMA Community Open.
Asymptomatic SARS-CoV-2 An infection Appears to Be Much less Widespread
MONDAY, Feb. 28, 2022 (HealthDay Information) — Utterly asymptomatic extreme acute respiratory syndrome coronavirus-2 an infection appears to be much less frequent than has been reported, in response to a examine printed on-line Feb. 14 in Open Discussion board Infectious Ailments.
Kids, Adults Can Transmit SARS-CoV-2 to Family Contacts
MONDAY, Feb. 28, 2022 (HealthDay Information) — Kids and adults inside a family can transmit and are vulnerable to an infection with extreme acute respiratory syndrome coronavirus 2, in response to a examine printed on-line Feb. 23 in Pediatrics.
Vaccine Rollout Linked to Drop in Extreme COVID-19 in Dialysis Sufferers
MONDAY, Feb. 28, 2022 (HealthDay Information) — The incidence of extreme COVID-19 infections was decrease than anticipated amongst dialysis sufferers from the start of vaccine rollout; and antibody titers in opposition to the SARS-CoV-2 spike protein lower considerably throughout the six months after COVID-19 vaccination in sufferers receiving upkeep dialysis, in response to two research printed on-line Feb. 10 within the Scientific Journal of the American Society of Nephrology.
Enhanced Exterior Counterpulsation Eases ‘Lengthy COVID’
MONDAY, Feb. 28, 2022 (HealthDay Information) — For sufferers with “lengthy COVID,” enhanced exterior counterpulsation therapy is related to enchancment in signs, together with fatigue and respiratory difficulties, in response to a examine offered on the American Faculty of Cardiology digital Cardiovascular Summit, held Feb. 16 to 19.
This text initially ran on consumer.healthday.com.
